Scarica l'app Stockscreener
311.96
6.32%
-21.50
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché CI Giù?
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$333.46
Aprire:
$324.08
Volume 24 ore:
2.16M
Relative Volume:
1.29
Capitalizzazione di mercato:
$88.96B
Reddito:
$254.47B
Utile/perdita netta:
$5.03B
Rapporto P/E:
17.27
EPS:
18.06
Flusso di cassa netto:
$6.01B
1 W Prestazione:
-6.19%
1M Prestazione:
-5.39%
6M Prestazione:
-8.09%
1 anno Prestazione:
-10.33%
Intervallo 1D:
$309.59
$328.25
Intervallo di 1 settimana:
$309.59
$337.25
Portata 52W:
$262.03
$370.82
Cigna Group Stock (CI) Company Profile
Nome
Cigna Group
Settore
Industria
Telefono
(860) 226-6000
Indirizzo
900 COTTAGE GROVE ROAD, BLOOMFIELD, CT
Confronta CI con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
CI
Cigna Group
|
312.13 | 88.96B | 254.47B | 5.03B | 6.01B | 18.06 |
|
UNH
Unitedhealth Group Inc
|
378.05 | 367.22B | 410.06B | 22.11B | 24.86B | 23.88 |
|
ELV
Elevance Health Inc
|
414.46 | 94.06B | 183.12B | 5.92B | 3.67B | 25.63 |
|
CVS
Cvs Health Corp
|
63.54 | 84.88B | 378.96B | 5.28B | 5.94B | 4.19 |
|
HUM
Humana Inc
|
250.59 | 30.98B | 117.76B | 1.21B | 2.39B | 9.95 |
Cigna Group Stock (CI) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-02-06 | Downgrade | Bernstein | Outperform → Mkt Perform |
| 2024-06-26 | Iniziato | Piper Sandler | Overweight |
| 2024-05-30 | Iniziato | Robert W. Baird | Outperform |
| 2024-03-06 | Iniziato | Barclays | Overweight |
| 2024-02-05 | Aggiornamento | Cantor Fitzgerald | Neutral → Overweight |
| 2024-02-05 | Aggiornamento | RBC Capital Mkts | Sector Perform → Outperform |
| 2024-02-01 | Aggiornamento | Deutsche Bank | Hold → Buy |
| 2024-01-04 | Aggiornamento | Bernstein | Mkt Perform → Outperform |
| 2023-12-11 | Aggiornamento | Jefferies | Hold → Buy |
| 2023-08-18 | Downgrade | Edward Jones | Buy → Hold |
| 2023-06-06 | Aggiornamento | BofA Securities | Neutral → Buy |
| 2023-04-21 | Iniziato | Cantor Fitzgerald | Neutral |
| 2023-04-05 | Aggiornamento | Raymond James | Outperform → Strong Buy |
| 2023-01-03 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2022-11-23 | Ripresa | Morgan Stanley | Overweight |
| 2022-11-21 | Downgrade | Raymond James | Strong Buy → Outperform |
| 2022-07-14 | Downgrade | Jefferies | Buy → Hold |
| 2022-06-22 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2022-06-17 | Iniziato | Loop Capital | Hold |
| 2022-05-27 | Ripresa | Bernstein | Mkt Perform |
| 2022-05-26 | Aggiornamento | BofA Securities | Underperform → Neutral |
| 2022-05-16 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2022-05-09 | Aggiornamento | Cowen | Market Perform → Outperform |
| 2022-02-07 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| 2022-02-04 | Downgrade | Deutsche Bank | Buy → Hold |
| 2022-01-06 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
| 2021-12-21 | Downgrade | JP Morgan | Overweight → Neutral |
| 2021-12-16 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2021-12-14 | Iniziato | Goldman | Neutral |
| 2021-11-17 | Iniziato | Seaport Research Partners | Buy |
| 2021-09-27 | Iniziato | SVB Leerink | Mkt Perform |
| 2021-09-10 | Downgrade | BofA Securities | Buy → Underperform |
| 2021-09-10 | Iniziato | Cowen | Market Perform |
| 2021-08-06 | Reiterato | BofA Securities | Buy |
| 2021-08-06 | Reiterato | Citigroup | Buy |
| 2021-08-06 | Reiterato | Deutsche Bank | Buy |
| 2021-08-06 | Reiterato | Jefferies | Buy |
| 2021-08-06 | Reiterato | Mizuho | Buy |
| 2021-08-06 | Reiterato | Oppenheimer | Outperform |
| 2021-08-06 | Reiterato | Truist | Buy |
| 2021-05-19 | Iniziato | Wells Fargo | Equal Weight |
| 2020-07-01 | Iniziato | SVB Leerink | Mkt Perform |
| 2020-05-04 | Downgrade | Bernstein | Outperform → Mkt Perform |
| 2020-03-24 | Aggiornamento | Raymond James | Outperform → Strong Buy |
| 2019-12-11 | Downgrade | Wells Fargo | Market Perform → Underperform |
| 2019-10-18 | Iniziato | Mizuho | Buy |
| 2019-09-30 | Aggiornamento | BMO Capital Markets | Market Perform → Outperform |
| 2019-09-12 | Iniziato | Deutsche Bank | Buy |
| 2019-08-06 | Aggiornamento | Bernstein | Mkt Perform → Outperform |
| 2019-04-23 | Iniziato | UBS | Buy |
| 2019-01-14 | Iniziato | Stephens | Overweight |
| 2018-12-24 | Iniziato | Edward Jones | Buy |
| 2018-03-13 | Iniziato | Bernstein | Mkt Perform |
| 2018-03-08 | Iniziato | Barclays | Overweight |
| 2018-01-03 | Iniziato | Goldman | Neutral |
| 2017-11-03 | Reiterato | RBC Capital Mkts | Outperform |
| 2017-06-22 | Reiterato | RBC Capital Mkts | Outperform |
| 2017-06-12 | Iniziato | Credit Suisse | Outperform |
| 2017-06-07 | Iniziato | Morgan Stanley | Overweight |
| 2017-05-08 | Reiterato | RBC Capital Mkts | Outperform |
| 2017-04-05 | Iniziato | Deutsche Bank | Buy |
Mostra tutto
Cigna Group Borsa (CI) Ultime notizie
Cigna (CI) Shares Dip on Presidential Push Against Drug Middleme - GuruFocus
Cigna, CVS down as Trump targets 'drug middlemen' in drug prices EO - Seeking Alpha
Cigna (CI) Receives Price Target Boost from Truist Analyst | CI Stock News - GuruFocus
Cigna (CI) Could Be Influenced by Proposed Medicaid Changes | CI Stock News - GuruFocus
Health insurance company denies operation to man battling lung cancer - KHOU
Man Fighting Cancer Now Battling Insurance Company After Life-Saving Transplant Denied - Men's Journal
Cigna lung transplant denial: Insurance company denies Deron Wells, Santa Monica, CA man with lung cancer, life-saving transplant - ABC7 Chicago
We Think Cigna Group's (NYSE:CI) Robust Earnings Are Conservative - simplywall.st
Cigna Group's (NYSE:CI) Performance Is Even Better Than Its Earnings Suggest - Yahoo Finance
Cigna insurance denies Santa Monica man a life-saving lung transplant as he was preparing to fly cross-country for procedure - ABC7 Los Angeles
The Cigna Group (CI): Among the Cheap ESG Stocks to Buy According to Hedge Funds - Yahoo Finance
11 Cheap ESG Stocks to Buy According to Hedge Funds - Insider Monkey
Cigna stock price target raised to $373 by Bernstein - Investing.com India
RBC Capital Adjusts Cigna Group Price Target to $371 From $355 - marketscreener.com
Cigna Group (CI) Stock Target Price Raised by Guggenheim | CI Stock News - GuruFocus
CFRA: Cigna Group ’faces industry-wide cost pressures’ By Investing.com - Investing.com South Africa
CFRA: Cigna Group ’faces industry-wide cost pressures’ - Investing.com Australia
Lionbridge Recognized with 2024 Cigna Healthy Workforce Designation™NORTHEAST - NORTHEAST - NEWS CHANNEL NEBRASKA
Guggenheim Adjusts Cigna Group Price Target to $388 From $384, Maintains Buy Rating - marketscreener.com
Cigna (CI) Price Target Increased on Positive Outlook | CI Stock News - GuruFocus
Deutsche Bank Adjusts Cigna Group Price Target to $372 From $356, Maintains Buy Rating - marketscreener.com
Raymond James Raises Price Target on Cigna Group to $385 From $360 - marketscreener.com
Piper Sandler Raises Price Target for Cigna Group (CI) to $374 | CI Stock News - GuruFocus
Cigna Packs Healthy Punch As Q1 Beat Sends Shares Higher, Analysts Raise Targets - Benzinga
Leerink Partners Adjusts Price Target on Cigna Group to $365 From $325, Maintains Market Perform Rating - marketscreener.com
Cigna Group (CI) Maintains "Buy" Rating from Guggenheim | CI Stock News - GuruFocus
CI: Cigna Group Stock Receives Boost from Morgan Stanley Rating | CI Stock News - GuruFocus
Cigna Group (CI) Price Target Raised by Barclays Analyst | CI St - GuruFocus
Cigna Group (CI) Price Target Raised by Barclays Analyst | CI Stock News - GuruFocus
Morgan Stanley Adjusts Cigna Group Price Target to $390 From $379, Maintains Overweight Rating - marketscreener.com
TD Cowen Adjusts Cigna Group Price Target to $386 From $380, Maintains Buy Rating - marketscreener.com
Jefferies & Co Adjusts Cigna Group Price Target to $397 From $376, Maintains Buy Rating - marketscreener.com
Cigna (CI) Target Price Increased by TD Cowen | CI Stock News - GuruFocus
Piper Sandler Elevates Cigna (CI) Price Target Amid Strong Performance | CI Stock News - GuruFocus
Cigna (CI) Price Target Raised by Morgan Stanley Analyst | CI Stock News - GuruFocus
Cigna (CI) Sees Price Target Increase Following Promising Q1 Results | CI Stock News - GuruFocus
Jefferies lifts Cigna stock price target to $397, maintains buy rating - Investing.com
Cigna (CI) Target Price Raised by Barclays Analyst | CI Stock Ne - GuruFocus
Cigna (CI) Target Price Raised by Barclays Analyst | CI Stock News - GuruFocus
Cigna raises 2025 outlook after lower-than-expected cost trends - MSN
MHE Week in Review –Cigna Revenue Increase, Aetna’s Exit and More - Managed Healthcare Executive
The Return Trends At Cigna Group (NYSE:CI) Look Promising - Yahoo Finance
The Cigna Group (CI) Q1 2025 Earnings Call Highlights: Strong Revenue Growth and Raised EPS Guidance - Yahoo Finance
The Cigna Group (CI) Q1 2025 Earnings Call Highlights: Strong Re - GuruFocus
Cigna Reports Strong Q1 2025 Results and Raises Outlook - TipRanks
Decoding The Cigna Group (CI): A Strategic SWOT Insight - GuruFocus
Cigna: Q1 Earnings Snapshot - MySA
Cigna’s Earnings Call: Strong Growth and Strategic Innovations - TipRanks
Cigna reports strong Q1, completes Medicare divestiture - InsuranceNewsNet
JPMorgan Adjusts Cigna Group's Price Target to $405 From $438 - marketscreener.com
Cigna (CI) Launches ENGUIDE Pharmacy Amid Growing GLP-1 Demand - GuruFocus
Cigna Group Azioni (CI) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
2.99%
2.14%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):